The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Squamousness: Next-generation sequencing to reveal shared molecular features across squamous tumor types.
 
Maria Clemence Schwaederle
No Relationships to Disclose
 
Sheryl Krevsky Elkin
Employment - N-of-One
Stock and Other Ownership Interests - N-of-One
 
Brett N. Tomson
Employment - N-of-One
 
Jennifer Carter
Employment - N-of-One
Leadership - N-of-One
Stock and Other Ownership Interests - N-of-One
 
Razelle Kurzrock
Stock and Other Ownership Interests - RScueRx
Honoraria - AACR; ASCO; Cancer Treament Centers of America; Cedars-Sinai; Clearview Healthcare Partners; CTRC-EAB San Antonio; Frankel Group; Janssen; Jubilant Biosys; Lynx Group; Merck; NCCN; SAIC NCI CCCT Investigational Drug Steering Committee; Segal Cancer Center; The Dedham Group; University of Arizona; Usha Mahajani Foundation
Consulting or Advisory Role - AACR; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; GlaxoSmithKline; GlaxoSmithKline; Merck; Merck; Novartis; Roche/Genentech; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - Cancer Treament Centers of America; EMD Serono; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Global Biomarkers Consortium; ICRP; WIN Pharma; WIN Pharma